IPDA Trademark

Trademark Overview


On Thursday, July 7, 2022, a trademark application was filed for IPDA with the United States Patent and Trademark Office. The USPTO has given the IPDA trademark a serial number of 97492456. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Accelevir Diagnostics, LLC. The IPDA trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic assay kits, namely, diagnostic kits comprised of medical diagnostic assays for testing of bodily fluids for use in disease detection, namely, HIV
ipda

General Information


Serial Number97492456
Word MarkIPDA
Filing DateThursday, July 7, 2022
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7422880
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesDiagnostic assay kits, namely, diagnostic kits comprised of medical diagnostic assays for testing of bodily fluids for use in disease detection, namely, HIV

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2023
Primary Code005
First Use Anywhere DateWednesday, February 28, 2024
First Use In Commerce DateWednesday, February 28, 2024

Trademark Owner History


Party NameAccelevir Diagnostics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202

Party NameAccelevir Diagnostics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202

Party NameAccelevir Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21202

Trademark Events


Event DateEvent Description
Monday, July 11, 2022NEW APPLICATION ENTERED
Tuesday, July 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 21, 2023ASSIGNED TO EXAMINER
Monday, April 24, 2023NON-FINAL ACTION WRITTEN
Monday, April 24, 2023NON-FINAL ACTION E-MAILED
Monday, April 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 20, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 20, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, June 20, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 20, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, June 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 18, 2024USE AMENDMENT FILED
Monday, March 18, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, April 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Saturday, April 6, 2024STATEMENT OF USE PROCESSING COMPLETE